Global Amplicon Sequencing Market Strategic Research Report

Scope of the Report

The global Amplicon Sequencing market size is predicted to grow from US$ 1,257 million in 2025 to US$ 2,379 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.

Amplicon Sequencing is a targeted next-generation sequencing (NGS) technology that focuses on specific regions of the genome, known as amplicons. It first uses polymerase chain reaction (PCR) to amplify these target regions, which effectively enriches the sequences of interest, then performs high-throughput sequencing on the amplified products. This method is characterized by high sensitivity, high specificity, and cost-effectiveness, as it avoids sequencing the entire genome and instead concentrates on key regions, making it suitable for detecting mutations, polymorphisms, and gene expression changes in specific genomic segments.

The demand for Amplicon Sequencing is showing steady growth driven by multiple factors, including the increasing emphasis on precise medicine in clinical practice, the expanding scope of genomic research, and the rising need for efficient and economical targeted sequencing solutions in both academic and industrial fields. Clinically, it is in high demand for tumor mutation detection, genetic disease screening, and infectious disease pathogen typing, while in research, it is widely used in population genetics, drug target discovery, and microbial diversity analysis. From a business perspective, key opportunities lie in providing customized amplicon sequencing services tailored to specific research or clinical needs, optimizing sequencing efficiency and data analysis capabilities to reduce costs and improve turnaround time, and expanding market penetration into emerging fields such as agricultural genomics and environmental microbiology, where there is growing demand for targeted and cost-effective sequencing technologies.

This report presents a comprehensive overview of the global Amplicon Sequencing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Sample Type

• Blood Sample Sequencing
• Tissue Sample Sequencing
• Cell Sample Sequencing

Segment by Target Region

• 16S rDNA Sequencing
• ITS Sequencing
• Target Region Amplicon Sequencing
• Others

Segment by Sequencing Depth

• Low-Depth Sequencing
• Medium-Depth Sequencing
• High-Depth Sequencing

Segment by Application

• Human Health and Clinical Research
• Agriculture and Food Safety
• Pharmaceutical and Biotechnology Research
• Forensics and Population Genetics
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Amplicon Sequencing market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Human Health and Clinical Research, Agriculture and Food Safety, Pharmaceutical and Biotechnology Research evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact